Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds
Health The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them. This image provided by Novo Nordisk in January 2023, shows packaging for the company’s Wegovy medication. According to a study published Saturday, Nov. 11, 2023, in the New England Journal … [Read more…]